Animal models ofhuman malignant skin melanoma were created in melanoma- 
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-8821], melanocs within the grad selectively proliferated in close proimity to areas of greatest wound healing, presumably in reponse to mitogenic factors fom ceils contributing to wound repair. An orderly sequence of externally visible events ed in malinant melanoma. We emne here the hisogenetic concomitants of these changes and find that they deflne a sepwie sequence striknly comparable to that leding to human cutaneous melanoma. Moreover, the histological detais suggest some ofthe underlying mechanisms. While the early lesions are first seen in the superficial dermis in the mouse, and in the basal layer of the epidermis in the human, both progress by radial growth followed by vertical growth. Melanocytic hyperplasa resulted in nests of densely melanied fisform cells which were lodng their dendrites. Some discrete lesons in the deep dermis appered as blue nevi. As radial proferation advanced, ceilular atypia insed and the preiouly independent melanocytes cohered dosely and formed a smail solid tumor; the ceils were usua_ly then hypomelanotic or amelanotic. Ulceration of tumor through the epidermis ourrd early. The tumor mass grew rapidly in the deep dermis and invaded and destroyed subcutaneous tissue and muscle. Primary tumors in the skin were often heterogeneous, with lobules or regions differing in pigmentation or atypia. However, the cells in crulating emboli, or in metastases in lymph nodes and lungs, appeared relatively homogeneous. These genetically uniform transgenic mouse models provide experimental access to the multistage genesis of melanoma.
The Tyr-SV40E transgene targets expression of the simian virus 40 oncogenic sequences to pigment cells in transgenic mice and results in spontaneous malignant melanomas of the eyes and various internal organs; skin melanomas tend to arise later (1, 2) and have only rarely attained malignancy before the mice die-usually of invasive and metastatic eye melanomas. This problem was recently overcome, and malignant skin melanomas were obtained, by taking advantage experimentally of the fact that different inbred lines of the mice differ in level of expression of the transgene and hence in degree of susceptibility to melanoma; yet all are members of the same standard strain, C57BL/6. Thus, by grafting skin from high-susceptibility transgenic donors to low-susceptibility transgenic hosts, the skin outlived the donors in immunocompetent hosts tolerant of the transgene product (3) .
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Unexpectedly, melanocytes in the grafted skin proliferated excessively and selectively, close to areas of greatest wound healing, especially near the graft margins (3) , thereby strongly suggesting a causal role of growth factors and cytokines associated with wound repair (4). The melanocytic lesions progressed to malignant melanoma in all skin grafts from the more susceptible of two transgenic donor lines tested, and in one-fourth of the grafts from another line; no melanomas of host onrgin developed. We have proposed that the induction of this maliancy in susceptible skin by wound healing is merely a caricature or exaggeration of the same basic biological and molecular events as ordinarily underlie the genesis of melanoma, without skin grafting, and that the exaggeration makes those events more accessible to analysis (3) .
From the externally visible evidence ofprogressive changes in the lesions, we concluded that the development of the transgenic melanomas bears a stiking resemblance to that of human skin melanomas and is an excellent in vivo model ofthe human malignancy (3) . This model has the further advantages of genetic uniformity and of the absence of any other kinds of skin tumors in the animals. In the present report, we describe the histogenetic evidence in support of a multistep tumor progression paralleling the sequence in human cutaneous melanomas. In addition, details visible only at the microscopic level suggest mechanisms on which some of the changes leading to malignancy may depend.
MATERIALS AND METHODS
The same transgenic mouse lesions as in the companion report (3) were examined histologically here. These orginated in donor body-skin grafts from line 8 [hemizygous for the transgene (Tag!-), and line 9 (Tag/Tag homozygotes), each developing in a line 12 (Tag!-) host. Wild-type bodyskin grafts, experimentally wounded but ungrafted transgenic skin, and unmanipulated wild-type and transgenic skin were also included. Tissues were fixed in neutral formalin, embedded in paraffin, and stained with hematoxylin/eosin. Some sections were immunostained as described (1) Proc. Natl. Acad. Sci. USA 90 (1993) 8823 epidermis and superficial dermis of body skin and synthesize melanin when the mice are exposed to ultraviolet light (6) . In contrast, pigmented melanocytes occur in the epidermis and dermis ofhuman body skin, especially in the basal layer ofthe epidermis (7) . The epidermis itself is much thinner in the haired areas of mouse skin than in human skin and has less-defined strata.
The body skin of Tyr-SV40E transgenic control mice was found to differ from wild-type controls of the same inbred strain in having occasional pigmented melanocytes in the superficial dermis and mid-dermis. In older transgenics, the cells were seen in the mid-dermis and deep dermis. Small flat black spots or macules also appeared spontaneously in the older transgenic mice. The macules had regular borders and consisted of groups of loosely associated pigment cells in the dermis. The accumulation of pigmented cells in unusual numbers or sites has also been described in various internal organs of the transgenic mice and was referred to as melanosis (2) .
Melacytic Hyperp_sa In Grafted Transgec Skin. After transplantation, the number of isolated melanocytes in the dermis increased, in comparison with ungrafted transgenic skin of similar age, so that scattered dendritic pigment cells were not difficult to find (Fig. la) . A much more striking change appeared within a few weeks after grfting and was readily apparent externally as a blackened localized ring just inside the margins of the graft and occasionally as a more irregular black tracery in the interior of the graft (3). These areas consisted of nests of discrete melanocytes in variable numbers; they clearly represented melanocytic hyperplasia, similar to early lesions after application of carcinogens to mouse skin, or carcinogens followed by exposure to ultraviolet light (8, 9) . The pigmented cells in our grafts were usually in the papillary and mid-dermis intermingled with dense collagen fibers (Fig. lb) .
Changes in Meanocyte Morphdogy. At this stage, the melanocytes gradually displayed several noteworthy changes. They were relatively elongated rather than epithelioid, their dendrites were greatly reduced in length and number, or even absent ( Fig. 1 b and f) , and melanization of the cells was markedly increased. Normal melanocytes in the skin characteristically have long dendritic processes through which pigment granules are exported to keratinocytes (or to hairs, when the cells are in the base of the hair follicles). Decreased dendricity of the hyperplastic transgenic melanocytes could thus lead indirectly to accumulation ofpigment granules in the cells and to hyperpigmentation. The intensified melanization is usually transitory; as the transgenic cells continue to change in other morphological respects (described below), they often become hypomelanotic or amelanotic.
The loss of dendrites is of particular interest because their continued presence would be an impediment to intimate adhesion between cells, as will presently occur in the formation of a solid melanoma. Experiments with cultured human melanocytes have shown that decreased dendricity may result when keratinocyte-derived soluble factors in the medium are withdrawn, and the decrease is reversible (10) . Certain mouse pigmentary mutations are also known to cause reduction of dendrites (11) . One ofthese encodes anunusual type ofmyosin heavy chain at the dilute locus (12) type in the animal's lungs appeared to come from this skin tumor rather than from other melanomas (chiefly ocular) in the same animal, as the others were of slightly different prevailing histological type.
Human skin melanomas originate from lesions in the basal layer of the epidermis (17, 18) , while the mouse lesions were first seen in the superficial dermis (Fig. 1 b-d) . This difference may be related in part to the thinness of the mouse epidermis and the concentration of pigmented cells chiefly in the hair follicles of mouse skin. Nevertheless, in both species the lesions progress by radial growth, followed by vertical growth into the dermis and subcutaneous tissue.
Ulceration. A more minor difference between mouse and human melanomas seems to be a tendency for slightly earlier Proc. Natl. Acad. Sci. USA 90 (1993) ..:. (Fig. lf) , but it is ulcerated over the nearby small melanoma (Fig. lg) , as well as over the more advanced tumor (Fig. lh) (Figs. lh and 2 b-e), even in skin from genetically identical mice. Many tumors in the grafts were multilobular, as in human melanomas. In the mouse skin grafts, the tumor lobes differed substantially in pigmentation, eosinophilia, and degree ofatypia (Figs. lh and 2c ). The spontaneous transgenic skin melanoma partly shown in Fig. 2a was in fact also multilobular and heterogeneous. A pigmented lobe ofthe experimental tumor in Fig. 2c , although macroscopically dense black, was microscopically a mixture of heavily pigmented and unpigmented cells; upon subcutaneous transplantation, this continued largely to be the case, but an occasional unpigmented segment arose. Some tumors did not appear multilobular but had regional differences within the tumor mass. Another variant was the occasional sharply discrete nodular tumor; the one in Fig. 2b is at an early stage and has not ulcerated. Some nodular tumors grew deeply into the subcutaneous tissue and could also protrude from the skin surface. Most tumors were hypomelanotic or amelanotic (Fig. 2 d and e) . (In Fig. 2d , the host tissue adjacent to the graft is distinguished by the presence of many hair follicles.)
Despite heterogeneity, the prevailing cell type within the tumors was epithelioid, with a lightly stained cytoplasm and hyperchromatic nuclei with prominent nucleoli; mitoses were numerous (Fig. 2e) and melanization was highly variable. All tumors were intensely positive for S-100 and most had some cells positive for HMB45. The relative tumorigenic potential of the spindle cells, small hyperchromatic cells, or other atypical subpopulations of cells is unknown. Whether the phenotypic heterogeneity is due to polyclonal oripgn or to divergent cellular evolution within the tumor is also unknown. Heterogeneity among cells of long-transplanted mouse melanoma cell lines has been well documented (19) . The transgenic mouse melanomas provide an opportunity to assess the oripgin and consequences of heterogeneity in newly developed primary skin melanomas.
Invasion. The rapid downgrowth oftumors proceeded from the dermis into the subcutaneous tissues, especially adipose and muscle tissue. In Metastais. Metastases were seen in three graft hosts (see table 1 in ref.
3) in the lymph nodes and lungs. In contrast to the obvious phenotypic heterogeneity of the primary tumors from which these metastases arose, the metastases themselves (and emboli) appeared relatively homogeneous, thereby suggesting origin from a subpopulation in the primary tumor. In Fig. 2f , a conspicuous amelanotic metastasis (from the primary skin tumor shown in Fig. 2e ) extends out from the lymphoid tissue. In the lung of another mouse, amelanotic tumor emboli are located in a blood vessel (Fig. 2g , arrowhead) while larger tumor masses are already established in the parenchyma. In Fig. 2h , from still another mouse, an amelanotic metastasis protrudes from the surface ofthe lung. Lymph nodes and lungs are the most common sites ofdistant metastases in human skin melanomas (20) . As the primary tumors in our mice varied greatly in size and progression at the time of autopsy, this may have precluded obtaining metastases in a larger number of hosts.
The Melanoma Model. The present histopathological findings support and extend the proposition, based on external observations (3) , that the skin graft-bearing Tyr-SV40E mice are uniquely favorable experimental models of human malignant skin melanoma. The series of changes and types of lesions in the mice parallel those in the human disease in virtually all respects. The mouse model offers the prospect of detailed molecular dissection of the in vivo steps toward malignancy and the mechanisms underlying melanoma metastasis. Unlike other candidate models of melanoma, these animals have no other skin tumors, are not immunologically compromised, and do not require repeated treatment. They are genetically uniform, with the same inbred-strain background as mouse strains bearing most of the genes known to affect pigment cells in particular and cell growth in general, so that such genes can be readily introduced into the transgenic system as single variables. And the use of transgenic lines with maximum vs. moderate melanoma incidence, as skin graft donors, enables suspected therapeutic vs. causal factors, respectively, to be tested in them.
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